pLV hUbC-Cas9-T2A-GFP Citations (9)
Originally described in: Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector.Kabadi AM, Ousterout DG, Hilton IB, Gersbach CA Nucleic Acids Res. 2014 Aug 13. pii: gku749. PubMed Journal
Articles Citing pLV hUbC-Cas9-T2A-GFP
| Articles |
|---|
| CTCF Expression is Essential for Somatic Cell Viability and Protection Against Cancer. Bailey CG, Metierre C, Feng Y, Baidya K, Filippova GN, Loukinov DI, Lobanenkov VV, Semaan C, Rasko JE. Int J Mol Sci. 2018 Nov 30;19(12). pii: ijms19123832. doi: 10.3390/ijms19123832. PubMed |
| Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene. Tso FY, West JT, Wood C. J Virol. 2019 Mar 21;93(7). pii: JVI.02183-18. doi: 10.1128/JVI.02183-18. Print 2019 Apr 1. PubMed |
| RUNX represses Pmp22 to drive neurofibromagenesis. Hall A, Choi K, Liu W, Rose J, Zhao C, Yu Y, Na Y, Cai Y, Coover RA, Lin Y, Dombi E, Kim M, Levanon D, Groner Y, Boscolo E, Pan D, Liu PP, Lu QR, Ratner N, Huang G, Wu J. Sci Adv. 2019 Apr 24;5(4):eaau8389. doi: 10.1126/sciadv.aau8389. eCollection 2019 Apr. PubMed |
| STX17 dynamically regulated by Fis1 induces mitophagy via hierarchical macroautophagic mechanism. Xian H, Yang Q, Xiao L, Shen HM, Liou YC. Nat Commun. 2019 May 3;10(1):2059. doi: 10.1038/s41467-019-10096-1. PubMed |
| Identification of a pituitary ERalpha-activated enhancer triggering the expression of Nr5a1, the earliest gonadotrope lineage-specific transcription factor. Pacini V, Petit F, Querat B, Laverriere JN, Cohen-Tannoudji J, L'hote D. Epigenetics Chromatin. 2019 Aug 7;12(1):48. doi: 10.1186/s13072-019-0291-8. PubMed |
Macrophage NFATC2 mediates angiogenic signaling during mycobacterial infection.
Brewer WJ, Xet-Mull AM, Yu A, Sweeney MI, Walton EM, Tobin DM.
Cell Rep. 2022 Dec 13;41(11):111817. doi: 10.1016/j.celrep.2022.111817.
PubMed
Associated Plasmids |
| Transcriptional regulation of Satb1 in mouse trophoblast stem cells. Yu W, Chakravarthi VP, Borosha S, Dilower I, Lee EB, Ratri A, Starks RR, Fields PE, Wolfe MW, Faruque MO, Tuteja G, Rumi MAK. Front Cell Dev Biol. 2022 Dec 14;10:918235. doi: 10.3389/fcell.2022.918235. eCollection 2022. PubMed |
| CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression. Cai H, Zhang B, Ahrenfeldt J, Joseph JV, Riedel M, Gao Z, Thomsen SK, Christensen DS, Bak RO, Hager H, Vendelbo MH, Gao X, Birkbak N, Thomsen MK. Nat Commun. 2024 Mar 7;15(1):2088. doi: 10.1038/s41467-024-46370-0. PubMed |
| The pancancer overexpressed NFYC Antisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action. Pandini C, Pagani G, Tassinari M, Vitale E, Bezzecchi E, Saadeldin MK, Doldi V, Giannuzzi G, Mantovani R, Chiara M, Ciarrocchi A, Gandellini P. Cell Death Dis. 2024 Mar 11;15(3):206. doi: 10.1038/s41419-024-06576-y. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.